These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


454 related items for PubMed ID: 23213931

  • 21. Dysplasia/neoplasia surveillance in oral lichen planus patients: a description of clinical criteria adopted at a single centre and their impact on prognosis.
    Mignogna MD, Fedele S, Lo Russo L.
    Oral Oncol; 2006 Sep; 42(8):819-24. PubMed ID: 16458570
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Progressive increase of human papillomavirus carriage rates in potentially malignant and malignant oral disorders with increasing malignant potential.
    Szarka K, Tar I, Fehér E, Gáll T, Kis A, Tóth ED, Boda R, Márton I, Gergely L.
    Oral Microbiol Immunol; 2009 Aug; 24(4):314-8. PubMed ID: 19572894
    [Abstract] [Full Text] [Related]

  • 27. Malignant transformation of oral leukoplakia: a follow-up study of a hospital-based population of 166 patients with oral leukoplakia from The Netherlands.
    Schepman KP, van der Meij EH, Smeele LE, van der Waal I.
    Oral Oncol; 1998 Jul; 34(4):270-5. PubMed ID: 9813722
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Aldehyde dehydrogenase 1 expression correlated with malignant potential of oral lichen planus.
    Xu Z, Shen Z, Shi L, Sun H, Liu W, Zhou Z.
    Ann Diagn Pathol; 2013 Oct; 17(5):408-11. PubMed ID: 23707659
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Role of TP53 in the progression of pre-malignant and malignant oral mucosal lesions. A follow-up study of 144 patients.
    Ogmundsdóttir HM, Björnsson J, Holbrook WP.
    J Oral Pathol Med; 2009 Aug; 38(7):565-71. PubMed ID: 19473450
    [Abstract] [Full Text] [Related]

  • 33. Evaluation of Potential Risk Factors that contribute to Malignant Transformation of Oral Lichen Planus: A Literature Review.
    Agha-Hosseini F, Sheykhbahaei N, SadrZadeh-Afshar MS.
    J Contemp Dent Pract; 2016 Aug 01; 17(8):692-701. PubMed ID: 27659090
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. [Research on malignant changes in oral lichen planus].
    Liu HW.
    Zhonghua Kou Qiang Yi Xue Za Zhi; 1994 May 01; 29(3):167-9. PubMed ID: 7867413
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. The clinical features, malignant potential, and systemic associations of oral lichen planus: a study of 723 patients.
    Eisen D.
    J Am Acad Dermatol; 2002 Feb 01; 46(2):207-14. PubMed ID: 11807431
    [Abstract] [Full Text] [Related]

  • 39. Overestimated risk of transformation in oral lichen planus.
    Cai X, Zhang J, Zhang H, Li T.
    Oral Oncol; 2022 Oct 01; 133():106025. PubMed ID: 35858493
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 23.